Next-generation trial shows five-drug combo can keep ‘ultra-high-risk’ bone marrow cancer at bay 23 Jun 2023 Combining five existing drugs can keep a highly aggressive type of bone marrow cancer at bay for longer, an innovative trial has shown. Find out more Show/Hide
Genetic test can guide treatment for blood cancer to help prevent relapse 19 Mar 2023 Scientists have found a new way to predict which patients with the blood cancer myeloma will benefit the most from a treatment often used to help keep the disease from coming back after a bone marrow transplant. Find out more Show/Hide
Trial identifies five-drug combo for ‘ultra high risk’ bone marrow cancer 12 Dec 2021 A combination of five existing drugs keeps cancer at bay for longer in patients with a highly aggressive type of bone marrow cancer, a major new trial reveals. Find out more Show/Hide
New myeloma clinical trial launches with aim to transform treatment from one-size-fits-all approach 10 Oct 2017